Profiling the activity of edible European macroalgae towards pharmacological targets for type 2 diabetes mellitus

Keyphrases

• Activity in Vivo 25%
• Alaria Esculenta 25%
• Antidiabetic Properties 25%
• Antihyperglycemic 25%
• Biotherapeutics 25%
• Brown Seaweed 25%
• Chlorophyta 25%
• Diabetes 25%
• Dipeptidyl peptidase-4 (DPP-4) 75%
• Edible Seaweed 50%
• Enzymatic Activity 25%
• Ethanol Extract 50%
• Europe 25%
• Glucagon-like 100%
• Glycemic Excursion 25%
• Inhibitory Effect 25%
• Kelp 25%
• Laminaria Digitata 25%
• Macroalgae 100%
• Marine Extracts 25%
• Medicinal Food 25%
• Oral Glucose Tolerance Test 25%
• Phaeophyceae 25%
• Pharmacological Targets 100%
• Porphyra 25%
• Rate of Increase 25%
• Rhodophyta 25%
• Seaweed Extract 50%
• Sodium-glucose Transporter 2 50%
• Traditional Medicine 25%
• Treatment Costs 25%
• Type 2 Diabetes Mellitus (T2DM) 100%
• Ulva Rigida 25%
• Water Extract 50%
• α-glucosidase 50%
• α-glucosidase Activity 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Algal Extract 50%
• Alpha Glucosidase 75%
• Antidiabetic Agent 25%
• Brown Alga 25%
• Dipeptidyl Peptidase IV 75%
• Edible Seaweed 75%
• Ethanol 50%
• Functional Food 25%
• Glucagon-Like Peptide-1 100%
• Glucose 25%
• Green Alga 25%
• Kelp 25%
• Laminaria 25%
• Macroalga 100%
• Marine Medicine 25%
• Maturity Onset Diabetes of the Young 100%
• Red Alga 25%
• Sodium Glucose Cotransporter 2 50%

Agricultural and Biological Sciences

• Alaria esculenta 25%
• Alpha-Glucosidase 75%
• Chlorophyta 25%
• Dipeptidyl Peptidase-4 75%
• Edible Seaweed 75%
• Enzyme Activity 25%
• Functional Food 25%
• Glucagon-Like Peptide-1 100%
• Glucose Tolerance Test 25%
• Kelp 25%
• Laminaria digitata 25%
• Macroalga 100%
• Phaeophyceae 25%
• Red Alga 25%
• Sodium Glucose Transporter 50%
• Traditional Medicine 25%